Table 2
Data recorded for ALTH and NLTH groups
| ALTH group (n = 413) | NLTH group (n = 69) | p Value | |
|---|---|---|---|
| Age (years) at first neuro-ophthalmology visit | 52.0 (15.4) | 56.0 (13.5) | 0.02 |
| Age (years) at first ocular dysfunction | 49.0 (15.6) | 54.4 (13.4) | 0.004 |
| Difference between age at 1st neuro-ophthalmology visit and 1st ocular dysfunction | 2.7 (5.3) | 1.3 (2.5) | 0.02 |
| BMI | 23.4 (4.0) | 26.3 (5.6) | <0.001 |
| Age adjusted (mean (SE)) | 23.4 (0.3) | 26.1 (0.8) | 0.001 |
| Sex | |||
| Male | 98 (24%) | 34 (49%) | <0.001 |
| Female | 315 (76%) | 35 (51%) | |
| Race | |||
| White | 249 (60.3%) | 43 (62.3%) | 0.34 |
| African-American | 27 (6.5%) | 2 (2.9%) | |
| Hispanic | 31 (7.5%) | 9 (13.0%) | |
| Asian | 43 (10.4%) | 4 (5.8%) | |
| Other | 63 (15.3%) | 11 (15.9%) | |
| Medical treatment for ophthalmopathy | 140 (34%) | 17 (25%) | 0.17 |
| Eye surgery | 217 (53%) | 23 (33%) | 0.004 |
| Autoimmune | 17 (4%) | 5 (7%) | 0.23 |
| Family history thyroid disease | 99 (24%) | 7 (10%) | 0.01 |
| History of radiation treatment for Graves’ ophthalmopathy | 18 (4%) | 1 (1.5%) | 0.50 |
| Hypercholesterol | 31 (7.5%) | 13 (19%) | 0.006 |
| Surgeries | |||
| Decompression | 100 (24%) | 5 (7%) | <0.001 |
| Strabismus | 208 (50%) | 18 (26%) | <0.001 |
| Levator | 88 (21%) | 5 (7%) | 0.005 |
| Lower lid retraction | 35 (8%) | 5 (7%) | 1.00 |
| Blepharoplasty | 64 (16%) | 7 (10%) | 0.28 |
